Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
EuroPCR’23: BIOADAPTOR RCT results comparing novel DynamX Bioadaptor to Resolute Onyx DES
Author(s): Shigeru Saito , Stefan Verheye Added: 2 years ago
Elixir Medical has announced positive results from the BIOADAPTOR RCT trial, comparing DynamX Bioadaptor to Resolute Onyx DES. The trial met its primary endpoint of TLF non-inferiority at 12 months. The bioadaptor demonstrated a TLF rate of 1.8% compared to 2.8% for the stent (p<0.001) and showed improved vessel function and pulsatility. Principal investigators DrShigeru Saito (Shonan Kamakura… View more

Intervention

Prevention & Chronic Conditions
Ep 9: Acute Results for Scaffold vs No Scaffold
Added: 1 year ago
Host, Dr Rasha Al-Lamee, is joined by Dr Luca Testa in this episode to compare the use of scaffolds versus no scaffolds, highlighting key differences. The discussion illuminates the standards and benchmarks that define success in DCB procedures, shedding light on the factors that contribute to favourable outcomes. They will also explain the rationale as to why no perfect results of DCB could be… View more

Intervention
TCT 2025: SELUTION DeNovo: 1-Year Results Comparing Sirolimus Balloon vs DES in PCI
Author(s): Christian Spaulding Added: 1 month ago
TCT 2025 — Prof Christian M Spaulding (European Hospital Georges Pompidou & INSERM U 970, FR), principal investigator of the SELUTION DeNovo trial (M.A. Med Alliance S.A.; NCT04859985), joins us to share the one year results.This international, multicentre randomised trial enrolled over 3,300 patients at 50 sites across Europe and Asia to compare a sirolimus-eluting balloon (SEB) plus provisional… View more

Intervention
NY Valves 25: The Tri-QOL Study
Author(s): Added: 5 months ago
New York Valves 25 - Quantitative findings from Tri-QOL showed a strong correlation between tricuspid regurgitation (TR) reduction and KCCQ improvement after transcatheter tricuspid valve intervention (TTVI).Dr Suzanne Arnold (Saint Luke's Mid America Heart Institute, Kansas City, US) discusses findings from a quantitative analysis from the Tri-QOL study which aimed to assess the optimal result… View more

Intervention
Immediate vs Deferred PCI in STEMI: iMODERN Trial Results
Added: 1 month ago Source:  Radcliffe Cardiology
The optimal timing for treating nonculprit lesions in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease remains a key clinical question. The iMODERN trial investigated whether an immediate intervention strategy was superior to a deferred approach in this patient population.¹The international, investigator-initiated, open-label iMODERN (Immediate or Deferred… View more

Imaging & Diagnostics

Intervention
Outcomes of CTO PCI in a Non-surgical Centre
Author(s): Thomas R Gilpin , Annette Maznyczka , Brijesh Anantharam , et al Added: 1 year ago

Intervention

Prevention & Chronic Conditions
LINC 25: The PATCH Study
Author(s): Sean Lyden Added: 10 months ago
LINC Conference 2025 - 30 day results of the PATCH study suggests the PerQSeal vascular closure device (Vivasure Medical Limited) can be used as an alternative percutaneous procedure for large-bore common femoral access, showing low risk of haematoma and a medium time of 0 minutes to achieve vessel closure.Dr Sean Lyden (Cleveland Clinic, Cleveland, OH, US) joins us to discuss the PATCH single… View more

Intervention

Vascular Disease and Surgery
Repeat TAVR Outcomes: Promising Results for Selected Patients with Failed TAVR
Author(s): Raj Makkar Added: 2 years ago
In this insightful interview, investigator, Prof Raj R Makkar(Cedars-Sinai Heart Institute, US) joins us to discuss the outcomes of repeat transcatheter aortic valve replacement with balloon-expandable valves. Prof Makkar and his team used the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry to address a series of questions regarding the safety… View more

Intervention
Urgent Surgery vs Fibrinolysis for Prosthetic Valve Thrombosis: SAFE-PVT Trial Results
Added: 2 months ago Source:  Transcatheter Academy
For patients with symptomatic left-sided mechanical prosthetic valve thrombosis (PVT), the optimal treatment strategy between urgent surgery and fibrinolytic therapy (FT) has been uncertain. The SAFE-PVT trial, the first randomised controlled trial (RCT) to directly compare these approaches, found that while surgery is associated with a higher risk of complications and death, FT often results in… View more

Anticoagulation

Guidelines & Statements
EuroPCR 24: 5-year Results of the SOLVE-TAVI trial
Author(s): Hans-Josef Feistritzer Added: 1 year ago
EuroPCR 24 - In this succinct interview, we are joined by Dr Hans-Josef Feistritzer (University of Leipzig, DE) to discuss the findings of the SOLVE-TAVI Trial.In recent years, trials such as CHOICE, REPRISE III, the SCOPE trial, PORTICO IDE and the SMART trial have privided increasing evidence for direct TACI valve comparisons as device designs improve. TAVI is increasingly performed using local… View more

Intervention